Thalidomide-O-PEG6-amine is a derivative of thalidomide, a drug that was initially developed as a sedative and anti-nausea medication but was later found to cause severe birth defects. Thalidomide-O-PEG6-amine is an amphiphilic molecule, meaning it contains both hydrophobic (water-hating) and hydrophilic (water-loving) parts. This allows it to be used as a delivery vehicle for drugs, such as chemotherapy agents, to target cancer cells while avoiding healthy cells. It has been used in clinical trials to treat various types of cancer, including multiple myeloma and metastatic breast cancer.
Thalidomide-O-PEG6-amine is a modified version of thalidomide that incorporates a polyethylene glycol (PEG) molecule. It has been studied for potential anti-inflammatory and anti-cancer properties, although it has not yet been approved for use in humans.
AxisPharm offers 5000+ PEG Linkers with high purity. Different kinds of PEG Reagents may be available by custom synthesis.
